Cross hepatotoxicity between tricyclic antidepressants.

Area of Science:

• Pharmacology
• Hepatology
• Toxicology

Background:

• Drug-induced liver injury (DILI) is a significant clinical concern.
• Cross-hepatotoxicity between different drug classes is uncommon.
• Tricyclic antidepressants (TCAs) are known for potential adverse effects, including liver injury.

Observation:

• A patient developed acute hepatitis following administration of amineptine, a TCA.
• The hepatitis recurred rapidly upon subsequent administration of clomipramine, another TCA.
• This clinical presentation raised suspicion for a shared toxicological pathway between the two agents.

Findings:

• The recurrence of acute hepatitis upon re-exposure to a structurally related drug strongly suggests cross-hepatotoxicity.
• The tricyclic ring structure of both amineptine and clomipramine is implicated as a potential factor in the observed liver damage.
• This case highlights a specific instance of cross-hepatotoxicity within the tricyclic antidepressant class.

Implications:

• The findings suggest that the tricyclic moiety may be a key determinant in the hepatotoxic potential of certain TCAs.
• Clinicians should exercise caution when prescribing related TCAs to patients with a history of unexplained hepatitis.
• Further research into the specific mechanisms of TCA-induced hepatotoxicity is warranted to identify at-risk individuals and develop preventative strategies.